Haemonetics (HAE) Tops Q2 EPS by 5c ; Offers Guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $72.78 +0.34%
Revenue Growth %: +2.3%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: +2.3%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $1.12, $0.05 better than the analyst estimate of $1.07. Revenue for the quarter came in at $346 million versus the consensus estimate of $342.58 million.
GUIDANCE:
Haemonetics sees FY2025 EPS of $4.45-$4.75, versus the consensus of $4.59.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Eldorado Gold elects nine directors at 2026 annual meeting
- Rocky Mountain Chocolate Factory (RMCF) files $6M mixed shelf
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
